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Sununary 
Suggestive evidence indicates that immunoglobulin  E (IgE)-dependent activation of mononuclear 
phagocytes plays an important pathogenic role in allergic tissue inflammation. Prevailing opinion 
holds that low affinity  IgE receptors are the relevant  IgE-binding structures on monocytes/ 
macrophages and that functional events occurring after cross-linking of membrane-bound IgE 
on these cells are mediated by these receptors. Here we demonstrate that Ix-ripheral  blood monocytes 
can bind monomeric IgE via the high affinity IgE receptor (FceRI) and that FceRI expression 
on these ceils is upregulated in atopic persons.  Further, we demonstrate that, upon monocyte 
adherence to substrate,  bridging of monocyte FcdLl is followed by cell activation. We propose 
that  direct  interaction  of multivalent  allergen  with  Fc~RI+-bound  IgE  on  mononuclear 
phagocytes results in cell signaling via Fcd~I and that the biological consequences of this event 
may critically influence the outcome of allergic reactions. 
T 
he observations that monocytes/macrophages  express IgE 
receptors (1, 2) and that IgE-mediated ligation of these 
moieties results in cell activation (3-7)  suggest that IgE- 
dependent activation of monocytes/macrophages  plays an im- 
portant role in the pathogenesis of allergic tissue injury. Low 
affinity IgE binding sites, i.e., the inducible form of the low 
affinity IgE receptor CD23 (1) and the IgE-binding protein 
eBP (2), are the only IgE-binding molecules so far detected 
on monocytes/macrophages. It was therefore assumed that 
these cell types preferentially bind preformed IgE complexes 
rather than monomeric IgE. Based on the observation that 
cellular binding of monomeric IgE via high affinity acceptor 
sites is not limited to mast cells and basophils, but also occurs 
with epidermal Langerhans cells (8, 9), we reevaluated the 
putatively exclusive role of low affinity IgE binding struc- 
tures for IgE binding to monocytes. Here we demonstrate 
that monocytes of atopic individuals can bind monomeric 
IgE and that this binding occurs via high affinity  Fc-IgE 
receptors similar to those described on basophils and mast 
cells (10). 
Materiah and Methods 
mAbs Used in Th/s  Study.  Anti-Leu-4  (CD3), anti-Leu-M3  FITC 
(CD14), anti-Leu-lla (CD16), anti-Leu-12 (CD19), anti-Leu-19 
(CD56; all from Becton Dickinson & Co. [BD],  1  Mountain View, 
CA); MHM6 (CD23; Dakopatts, Glostrup, Denmark); IV-3 Fab 
(CDw32), 32.2 F(ab')2 (CD64; both from Medarex, Inc., West 
Lebanon, NH);  chimeric human IgE (clgE) and IgG2 (cIgG2) 
anti-NP (4-hy&oxy-3-nitrophenacetyl;  both from Serotec, Inc., Ox- 
ford, UK); 15-1 and 19-1 (anti-Fc.dLl,  reference  8); and VIAP (anti- 
alkaline phosphatase, IgG1 control mAb), 7E4 (CD31, reference 
11; both provided by Dr. W. Knapp, Institute of Immunology, 
University of Vienna Medical School) were used. Fab and F(ab')2 
fragments of mAbs were generated using kits form Pierce Chem- 
ical Co. (Rockford, IL). 
Cell Preparations and Cell Lines.  T ceLl-depleted  mononuclear 
cells (E--MNC) were prepared by density gradient centrifugation 
of heparinized  venous  blood followed  by depletion  of StLBC-binding 
cells (E +-MNC). E--MNC from buffy coats of atopic individuals, 
i.e., patients suffering from either allergic rhinoconjunctivitis (as 
defined  by clinical  criteria, skin prick test, and radioailergosorbent 
test) and/or atopic dermatitis (diagnosed according to the criteria 
cited in reference 12), were subjected to anti-CD3-, anti-CD16-, 
anti-CD19-,  and anti-CD56-immunomagnetic  depletion (Dy- 
nabeads M-450; Dynal A.S., Oslo, Norway), and monocytes were 
1 Abbreviations used in this paper: AD,  atopic dermititus; BD, Becton 
Dickinson  & Co.; CHO cells, Chinese  hamster  ovary  ceils; CHS, allergic 
contact hypersensitivity;  CU, chronic  urticuria; MPC, mean  fluorescence 
channel; MNC, mononuclear  cells; RC, allergic  rhinoconjunctivitis;  SA, 
streptavidin. 
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Percoll gradient (d  =  1.062 g/ml).  The interface cells regularly 
consisted  of 95-97% CD14  sright monocytes and 0.5-2% toluidine 
blue-positive basophils.  Cells denser than 1.062 g/ml consisted of 
13-40% basophils.  T cells were purified by subjecting E+-MNC 
to hypotonic shock and immunomagnetic depletion of CD19-, 
CD16-, and/or CD56-positive cells. Chinese hamster ovary (CHO) 
cells were obtained from the American Type Culture Collection 
(Rockville,  MD).  Stable  transfectants  coexpressing  the  human 
FceRIc~- and FceRIy-chain (CHOay cells) have been described (8). 
lmmunofluorescence Double Labeling and Flow Cytometric Anal- 
ysis.  To release putative in vivo bound IgE molecules from mono- 
cyte surfaces, E--MNC were subjected  to acid stripping (0.05 M 
Tris-HC1,  pH 2.5,  1 rain on ice) followed by RPMI  1640/10% 
FCS (both from Gibco Ltd., Paisley, Scotland).  106 E--MNC were 
exposed to 5/zg/ml anti-Leu-M3 FITC and to either 5/xg/ml bi- 
otinylated 15-1, 10/~g/ml biotinylated 15-1 F(ab')2, 10/zg/ml bi- 
otinylated F(ab')2 fragments of the irrelevant isotype-matched IgG1 
control mAb VIAP, or biotinylated clgE (1, 5, or 25 #g/ml). Cell- 
bound biotinylated mAbs were visualized by streptavidin-PE  (SA- 
PE, 1/zg/ml; BD). In selected experiments, E--MNCs were in- 
cubated for 30 rain with graded doses (20,  100, or 500/xg/ml) 
of either clgE, clgG2, or Fc fragments of polyclonal human serum 
IgG (hulgG Fc; Chemicon International, Inc., Temecula, CA) be- 
fore exposure  to biotinylated  15-1 or  15-1 F(ab')2. Conversely, 
E--MNC were incubated with 50/zg/ml of either 15-1 F(ab')2, 
MHM6,  IV-3 Fab,  or  32.2  F(ab')2 before the  reaction  with  5 
/zg/ml biotinylated clgE. Cellular fluorescence  and light scatter 
parameters  were analyzed on a FACScan  |  (BD). Monocytes were 
gated simultaneously by their high CD14 expression and by their 
typical orthogonal light scatter characteristics.  The specific reac- 
tivity of biotinylated 15-1 F(ab')2 was  expressed  as the A-mean 
fluorescence channel number (A-MFC: MFC of 15-1 F(ab')2 reac- 
tivity minus MFC of the reactivity of the IgG1 F(ab')2 control 
mAb). Alternatively, the specific reactivity of intact mAb 15-1 was 
calculated by subtracting the MFC of biotinylated 15-1 reactivity 
in the presence of 500/zg/ml clgE from the MFC of 15-1 reactivity 
in the absence of clgE. The specific binding of biotinylated clgE 
was calculated by subtracting the MFC of the medium control from 
the MFC of clgE reactivity. Statistical significances were determined 
using the unpaired Student's t test and p <0.05 was considered to 
be statistically  significant. 
Cytoplasmic RNA  Preparation and Northern Blotting.  5  x  107 
purified monocytes, purified T  cells, and T  cells artificially con- 
taminated with basophil numbers equivalent to those present in 
the monocyte preparation were solubilized and cytoplasmic RNA 
was extracted as described (13). Controls included RNA obtained 
from murine skin, CHO, and CHOccy cells. 15 lag RNA of each 
preparation was electrophoresed on a 1.2% agarose/formaldehyde 
gel and transferred to a GeneScreen  TM nylon membrane (New En- 
gland  Nuclear,  Boston,  MA).  Hybridization probes  were:  (a) 
FcelLI'y (14), 300-bp Bsp1286I-XbaI cDNA fragment; (b) FcetLIcr 
(15), 900-bp PstI-EcolLl cDNA fragment, and (c) 3-actin, 34-meric 
oligonucleotide (16).  cDNA  probes  were labeled  with  ot-[32p]  - 
dATP (Amersham International,  Buckinghamshire, UK) by random 
priming, and labeling of the 3-actin probe was achieved by adding 
cr  to its 3' end using terminal transferase  (Boehringer 
Mannheim Biochemicals, Mannheim, Germany). Prehybridization, 
hybridization, and washes were performed by standard procedures 
(17). Blots were exposed to Kodak X-Omat AtL films in the pres- 
ence of intensifying screens at  -70~  and were stripped before 
rehybridization. 
Western Blotting.  5  x  107 cells of each population were solu- 
bilized in 500 #1 Tris-lysis buffer/l% NP-40/0.1% deoxycholic acid 
(both from Sigma Chemical Co., St. Louis, MO). Equal quantities 
of lysates (except for CHO and CHOoty cells) were separated on 
10 or 13% SDS-polyacrylamide  gels and electroblotted onto Hy- 
bond C nitrocellulose membranes (Amersham International).  Mem- 
branes were blocked in  5%  dry milk/0.05%  Tween 20 (Sigma 
Chemical Co.)/PBS, and incubated with either 175 ng/ml mAb 
19-1,  175  ng/ml  mAb  7E4,  or  a  1:40,000  dilution  of rabbit 
anti-human FceRIy (18).  Membrane-bound first-step  Abs were 
reacted with either goat anti-mouse or goat anti-rabbit horseradish 
peroxidase conjugates (both from Bio-Rad Laboratories, Richmond, 
CA). Membrane-bound second-step Abs were visualized with ECL  | 
developing solution (Amersham International) and exposed to Kodak 
X-Omat S films. 
Measurement of Cytosolic Ca 2+  Mobilization.  E  -MNC  were 
subjected  to  lactic  acid  stripping  as  described  (19).  4  x  106 
E--MNC in RPMI 1640/10% FCS were allowed to adhere to in- 
dividual wells of 48-well tissue culture plates (Costar Corp., Cam- 
bridge, MA) for 2 h  at 37~  Nonadherent cells were removed 
by rinsing the wells. 80-90% of the adherent cell population was 
CD14 positive; no toluidine blue-positive cells were detected. After 
washing  in  HBSS  (GIBCO  BRL,  Gaithersburg,  MD)/1  mM 
CaC12/0.5  mM MgC12 (HBSS/Ca/Mg),  cells were loaded with 
Fluo-3 acetoxymethyl ester and Pluronic F-127 (both from Molec- 
ular Probes Inc., Eugene, OR) as described (20). After a 10-rain 
incubation at room temperature, HBSS/Ca/Mg/1% FCS was added 
for another 40 rain. Adherent cells were rinsed with Hepes-buffered 
medium  (137 mM  NaC1,  5  mM KC1,  5  mM  glucose,  1 mM 
CaC12, 0.5 mM MgC12, 10 mM Hepes,  1 mM Na2HPO4-12 H20, 
1 mg/ml BSA; pH 7.3) and were exposed to 20 #g/ml F(ab')2 or 
Fab fragments of various mAbs for 20 min at room temperature. 
After rinsing with Hepes-buffered medium, plates were examined 
under a confocal laser scanning device (MRC 600; Bio-Rad Labora- 
tories; excitation wavelength, 488 nm) mounted onto an inverted 
microscope (Axiovert 10; Carl Zeiss, Inc., Oberkochen, Germany). 
Cell-bound mAb fragments were cross-linked  by adding affinity- 
purified sheep anti-mouse IgG F(ab')~ (Amersham International) 
to a final concentration of 10/xg/ml. Cellular fluorescence was peri- 
odically  measured at  an emission  wavelength of 515  nm.  After 
monitoring Ab-induced changes,  500  ng/ml ionomycin (Sigma 
Chemical Co.) was added for maximal induction of the cytosolic 
[Ca2+]. The peak fluorescence intensities  of 30 randomly selected 
single cells were determined and data expressed as fluorescence in- 
tensity channel number on a scale ranging from 1 to 255. 
Results and Discussion 
Peripheral  blood  monocytes  from  atopic  donors  were 
identified by their high CD14 expression and by their typical 
cellular granularity (Fig. 1 A). When selected by gating, these 
cells (five individual donors)  showed a homogeneous reac- 
tivity with F(ab')2 fragments of the anti-FceRIot mAb 15-1 
(Fig. 1 C) but did not bind F(ab')2 fragments of an isotype- 
matched IgG1 control mAb (Fig. 1 B). The specificity of 15-1 
F(ab')2 binding  to monocyte FcelLI was  confirmed by the 
complete inhibition of anti-FceRIot reactivity after preincu- 
bation of the cells with monomeric human IgE (clgE) but 
not with monomeric human IgG2 (clgG2) or human IgG 
Fc  fragments  (hulgG  Fc;  Fig.  1  D).  In  reverse  fashion, 
FceRI § monocytes of atopic individuals bound monomeric 
IgE at low concentrations (Fig. 1 E) whereas FceRI-  mono- 
cytes from healthy donors failed to do so (data not shown). 
746  FceRI Expression on Monocytes of Atopic Individuals Figure  1.  Flow  cytometric analysis of monocyte Fc~ILI0t  expression and FcER.lot-mediated  monomeric IgE binding. Representative experiment. (A) 
Peripheral blood monocytes as identified by intense reactivity with a FITC-hbded anti-CD14 mAb (absc/ssa)  and typical orthogonal light scatter charac- 
teristics (ordinate) were gated for the analysis of Fc~lLIot  expression and IgE-binding capacity. Reactivity of gated monocytes with biotinyhted  F(ab')2 
fragments of an Ig,  G1 control mAb (B) or with biotinylated mAb 15-1 F(ab')2 (C; open histogram) as visualized by streptavidin (SA)-PE. Closed histo- 
grams give the reactivity of SA-PE alone. Logarithmically amplified PE fluorescence  is given on the abscissa  and the relative cell number on the ordinate. 
(D) 15-1 F(ab')z reactivity of gated monocytes (ordinate) in the absence (open  circle) or in the presence of increasing concentrations (abscissa) of the cIgE 
(closed squares), cIgG2 (open  squares), or huIgG Fc (open triangles). (E) Reactivity of gated monocytes with graded doses of biotinylated clgE as detected 
by SA-PE (open histograms) or with SA-PE alone (closed histogram). (F) Binding of biotinylated clgE to monocytes (A-MFC, ordinate) after preincubation 
of the cells with either medium  or 15-1 F(ab')2, MHM6 (CD23),  IV-3 Fab (CDw32),  or 32.2 F(ab')2 (CD64). 
While these data strongly suggest that monocyte Fc6ILIo~ 
is responsible  for the observed monomeric  IgE-binding, a pos- 
sible contribution of CD23 or even Fc'yK was not formally 
excluded. To address this issue we tested a panel of anti-FcR 
mAbs for  IgE-binding inhibition. Selectively, mAb  15-1, 
directed against the IgE-binding site of F~P,I, completely 
abolished the binding of monomeric  IgE to monocytes (Fig. 
1 F). In contrast,  mAbs to FcdLII (MHM6), Fc3,ILI (32.2 
F(ab')z), or FcTRII  (IV-3 Fab) did not interfere with this 
binding (Fig.  1 F).  We therefore conclude that ~EKIc~ is 
expressed on monocytes of atopic individuals and is the only 
structure capable of binding monomeric IgE on these calls. 
To search for a linkage between  I~tLI expression  on mono- 
cytes and allergic diseases we investigated the occurrence of 
monocyte I~lLIot expression  in healthy adult volunteers (CO) 
and in pat/ents suffering from atopic dermatitis (AD), allergic 
rhinoconjunctivitis (R.C), chronic urticaria (CU), and allergic 
contact hypersensitivity (CHS). We found that specific, i.e., 
IgE-;nh;bitable, 15-1  binding to monocytes  was significantly 
(p <0.05) upteguhted in atopic individuals (AD, RC) as com- 
pared with the nonatopic control groups in which almost 
no (CO, CHS) or only moderate (CU) ~lLIoe expression 
was observed (Fig. 2). 
To glean information about the molecular composition of 
the high affanity IgE receptor on monocytes, we screened R.NA 
from  "monocytes" (>95%  CD14-positive,  1%  toluidine 
blue-positive cells)  from two atopic individuals for transcripts 
encoding the various chains of FceRI expressed in basophils 
and mast cells (10) and detected specific  hybridization signals 
with the FcelLIot (1.1 kb; Fig. 3 A) and the FcelLb/(0.8 
kb;  Fig.  3  B)  probes.  Since hybridization  of basophil- 
contaminated T  cell RNA with the same eDNA probes 
yielded comparatively much fainter signals, we could exclude 
the possibility  that the Fc~RI transcripts observed  in the mono- 
cyte RNA preparation originated from contaminating baso- 
phils. For unknown reasons, we could not detect FcePdfl 
taR.HA in the monocyte preparations. Apart from procedural 
considerations, the possibility exists that the high affinity ~- 
IgE receptor on monocytes consists of oe and 3, chains only. 
In fact, this composition reportedly sutfices for cell surface 
expression of the human receptor (21). 
Molecular mass characteristics of monocyte l~cetLIa and 
F'celLI3, were studied by Western blot analysis. Lysates  of var- 
ious cell types were subjected to SDS-PAGE, blotted onto 
nitrocellulose,  and developed  with either the anti-F~Pdol mAb 
19-1 (Fig. 3 C, left), the isotype-matched control mAb 7E4 
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Figure  2.  Monocyte FceRIo~ expression is significantly upregulated in 
atopic individuals.  FceRI~ expression  (oral/ante) of monocytes from pa- 
tients suffering from atopic dermatitis (AD),  allergic rhinoconjunctivitis 
(RC), chronic urticaria (CU), allergic contact hypersensitivity  (CH$), and 
healthy adult volunteers  (CO) is depicted (open  circles). Specific mAb 15-1 
reactivity of monocytes (A-MFC) was calculated as described in Materials 
and Methods. clgE-inhibited mAb 15-1 reactivity, i.e., nonspecific reac- 
tivity, was comparable in all groups investigated (data not shown). Open 
bars demonstrate the ran~ from the 25th  to the 75th percentile of the 
distribution of individual FceRIcx exp~cssinn in each group and horizontal 
lines indicate the median level of Fc~RIc~ expression  of each group. 
(Hg. 3 C, right),  or an antiserum to FceRI  7  (Fig. 3 D). We 
found identical  molecular  mass  properties  for  monocyte-, 
basophil-, and CHOor~-F'ceRIot and FcelLI  7  (50-70 and 18 
kD, respectively).  Control lysates displayed either no (T cells 
and CHO cells), or only very faint (T cells plus 1% basophils), 
reactivity with anti-FceRIol and anti-FceRI  7  reagents.  Thus, 
we conclude that monocytes can express FceILIot and FceRI  7 
chains and that their molecular mass characteristics correspond 
to  those encountered  on basophils. 
To determine  whether  monocyte  FceRI  expression is of 
functional significance, we looked for signal transduction oc- 
curring after receptor  ligation with Fab or F(ab')z fragments 
ofmAb 15-1 and FceRI cross-linking with sheep anti-mouse 
Ig43 F(ab')2. Fig. 4 shows that FceRI is capable  of mediating 
a sustained cytosolic Ca  2  + increase in plastic-adherent  mono- 
cytes quantitatively comparable to that introduced via FeyRII. 
In contrast,  in non-plastic-bound FcetkI + monocytes no, or 
only  minimal,  FceRI-mediated  elevation  of  the  cytosolic 
Ca  2+  concentration  occurred,  although  these  cells  vigor- 
ously responded to Fc3,RII cross-linking (data not shown). 
We therefore conclude that the activation state of monocytes 
determines the functionality of FcetLI expressed on their sur- 
faces.  Thus,  it is conceivable  that a robust FceRI-mediated 
Ca  2+  response of mononuclear phagocytes in vivo depends 
on their attachment to cellular substrates and/or matrix pro- 
teins. Similar activation requirements have been proposed for 
Figure  3.  Periphcralblood monocytes ofatopic 
individuals e~press  FceRIo~ and Fc~RI  7  at  the 
mRNA and protein level Representative  experi- 
ments.  Cytoplasmic RNA from CHOoL  7  cells, 
CHO  ceUs, monocytes containing  1%  residual 
basophils,  autologous  T  cells  mixed with  1% 
basophils,  pure T  cells, and routine skin was hy- 
bridized to 32p-labeled  FcAILIol  (.4) or FcePd  7  (B) 
cDNA probes.  Hybridization to a 3-actin probe 
confirmed that comparable amounts of RNA had 
been loaded in alllanes (data not shown). (C) Cell 
lysates of CHO  cells, CHOol  7  cells, basophils, 
monocytes containing 1% residual basophils, T cells 
mixed with 1% basophils, and pure T calls were 
size fractionated by SDS-PAGE and analyzed by 
Western blotting for F~ILIc,  expression using mAb 
19-1 (left). For control purposes, CD31 ~pression 
was determined using the isotype-matched mAb 
7E4 (right). The high molecular mass band in the 
monocyte lane corresponds to residual mouse mAbs 
from the purification procedure.  Molecular mass 
calibration  is shown on the left in kilodaltons. (D) 
Reactivity of the cell lysates  with rabbit anti-human 
FcdLI  7. Normal rabbit serum yielded  no reactivity 
(data  not shown). 
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Figure 4.  Elevation  of cytosolic  free Ca  2+ 
after cross-linking  of  monocyte  ~elLI. Repre- 
sentative  e~aa'iment.  (.4) Huo-31  _o~'d___,  plasti~ 
adherent E--MNC were reacted with either 
15-1 F(ab')2 (solid line), 15-1 Fab (dotted line), 
iv.3 r.ab (~hrd line), or with an IgG1 F(ab')z 
control mAb (solid  line~open  circles). CeU-bound 
main were  eross-lin~ with sheep  anti-mousc 
IgG F(ab')z at the indicated time point. Cd- 
lular Fho-3 fluorescence,  as a relative  measure 
of the  cytosolic Ca  2+  concentration, was 
monitored in 6-s intervals over a total time of 
180 s by laser video microscopy. The mean 
fluorescence  intensity  eh~nnd number (oral/hate) 
of 30 individual  cells  for each investigated  time 
point was plotted vs. the elapsed time (absc/ssa). 
(B) At the end of the monitoring period, 
ionomycin  was added to each reaction  in order 
to maximally  increase intraccHuhr  Ca2+ con- 
centrations. The mean fluorescence  intensity 
(ordinate) of the same 30 cells monitored in A 
is displayed. 
rat basophih'c leukemia cells in which the adherence-dependent 
activation  of the  focal  adhesion  kinase p125  F~  amplifies 
signal transduction via FceRI (22). 
The IgE-mediated allergic reaction has so far been solely 
attributed to biological events initiated by the interaction of 
multivalent allergens with mast cdl/basophil-bound IgE mol- 
ecules (23, 24). The recent discovery of FcdLI on Langerhans 
ceils (8, 9) and the demonstration of functionally active F~tLI 
on adherent mononuclear phagocytes (this study) possibly 
add a new facet to our understanding of the pathogenesis 
of IgE-mediated allergic reactions. In atopic individuals, the 
allergic reaction is often composed of an immediate wheal 
and flare response and a chronic late phase reaction (24). Our 
results suggest:  (a)  that not only mast cells/basophils but 
also mononudear phagocytes of atopic individuals carry FcdLI- 
bound monomeric IgE molecules; and (b) that, in addition 
to mast cells/basophils, IgE-bearing, Fc,  dLI + monocyte-de- 
rived tissue macrophages become directly activated after the 
interaction with multivalent allergens. This may result in en- 
hanced allergen presentation by these ceils and/or in the syn- 
thesis and release of proinflammatory cytokines (3), eicosa- 
noids (4, 5), enzymes (6), or oxygen radicals (7) in a pattern 
not  necessarily identical  to  that  seen with mast ceils and 
basophils.  Thus,  the interaction of allergen with FceRI +- 
bound allergen-specific IgE on macrophages may critica]ly 
influence the duration, quality, and quantity of allergic reac- 
tions. 
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